Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-03-005041PMID 16684959PMCID PMC1895515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Graft-versus-host disease

  2007cited by this paper
• Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

  2006cited by this paper
• Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation.

  2005cited by this paper
• Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion

  2005cited by this paper
• Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party

  2005cited by this paper
• Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.

  2004cited by this paper
• Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.

  2004cited by this paper
• Long-term outcome after bone marrow transplantation for severe aplastic anemia.

  2004cited by this paper
• Increased Serum Levels of Tumor Necrosis Factor a ! Precede Major Complications of Bone Marrow Transplantation

  2003cited by this paper
• HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

  2003cited by this paper
• Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

  2002cited by this paper
• Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.

  2001influential reference
• Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

  2001cited by this paper
• Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.

  2001influential reference
• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

  2001cited by this paper
• Improving availability and safety of unrelated donor transplants

  2000cited by this paper
• Current Results of Bone Marrow Transplantation in Patients with Acquired Severe Aplastic Anemia

  2000cited by this paper
• Long‐term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation

  2000cited by this paper
• Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia

  1999cited by this paper
• Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.

  1999cited by this paper
• Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia.

  1999cited by this paper
• Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

  1999cited by this paper
• Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

  1998cited by this paper
• Defunct hematopoietic progenitor growth and heterogeneous immunological phenotypes in acquired aplastic anemia of childhood: identification of subsets with decreased hematopoietic progenitors and increased IL15 or IL10 production.

  1998cited by this paper
• Methods for assessment of graft-versus-host disease.

  1998cited by this paper
• Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.

  1998cited by this paper
• High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation

  1997cited by this paper
• Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.

  1997cited by this paper
• Primary Treatment of Acquired Aplastic Anemia: Outcomes with Bone Marrow Transplantation and Immunosuppressive Therapy

  1997cited by this paper
• Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.

  1996cited by this paper
• Overproduction of inhibitory hematopoietic cytokines by lipopolysaccharide-activated peripheral blood mononuclear cells in patients with aplastic anemia

  1995cited by this paper
• Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors.

  1994cited by this paper
• Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

  1993cited by this paper
• Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

  1993cited by this paper
• Marrow transplantation for severe aplastic anemia and thalassemia major.

  1991cited by this paper
• Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis.

  1991cited by this paper
• Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

  1990cited by this paper
• Regimen-related toxicity in patients undergoing bone marrow transplantation.

  1988cited by this paper
• Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia.

  1986cited by this paper
• [Graft-versus-host disease].

  1986cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper
• Marrow transplantation in aplastic anemia.

  1974cited by this paper

• Carbamazepine-induced aplastic anemia: A rare reported adverse drug reaction

  2026cites this paper
• Comparative study of Bu/Cy/ATG and Flu/Cy/ATG conditioning regimens for unrelated donor hematopoietic stem cell transplantation in severe aplastic anemia.

  2025cites this paper
• Future directions in transplantation for aplastic anemia.

  2025cites this paper
• Co-transplantation of umbilical cord mesenchymal stem cells and peripheral blood stem cells in children and adolescents with refractory or relapsed severe aplastic anemia

  2024cites this paper
• The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults

  2024cites this paper
• Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study

  2024cites this paper
• Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP).

  2024cites this paper
• Pre-Transplant Platelet Refractoriness and Alternative Donors Are Associated With Cytomegalovirus Retinitis in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia

  2022cites this paper
• Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia

  2021cites this paper
• Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6–7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years

  2021cites this paper
• Hematopoietic Cell Transplant for Severe Aplastic Anemia

  2021cites this paper
• Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome

  2021cites this paper
• Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation

  2021cites this paper
• Outcomes of haploidentical stem cell transplantation using total body irradiation (600 cGy) and fludarabine with ATG in adult patients with severe aplastic anemia: A prospective phase II study.

  2020cites this paper
• Fludarabine, Campath and Low dose Cyclophosphamide (FCClow) with or without TBI Conditioning Results in Excellent Transplant Outcomes in Children with Severe Aplastic Anemia.

  2020cites this paper
• Characteristics of immunomorphological processes in the spleen of patients with immune thrombocytopenia

  2020cites this paper
• Acquired Aplastic Anemia

  2020cites this paper
• Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia.

  2020cites this paper
• Comparison of HLA-matched sibling and unrelated donor transplantation in adult patients with acquired severe aplastic anemia

  2020cites this paper
• Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia

  2020cites this paper
• A case series of post-transplant cyclophosphamide in unrelated donor hematopoietic transplantation for aplastic anemia.

  2020cites this paper
• High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications.

  2020cites this paper
• A single institution experience of total lymphoid irradiation using helical tomotherapy as part of the conditioning regimen of transplantation for severe aplastic anemia patients

  2020cites this paper
• Cord blood transplantation for bone marrow failure syndromes: state of art.

  2019cites this paper
• Posttransplant cyclophosphamide in allogeneic bone marrow transplantation for the treatment of nonmalignant hematological diseases

  2019cites this paper
• Aplasia Medular

  2019cites this paper
• Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells.

  2019cites this paper
• Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia.

  2019cites this paper
• Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

  2019cites this paper
• 脐血间充质干细胞在难治性重型再生障碍性贫血异基因造血干细胞移植中的应用

  2019cites this paper
• Engraftment, Graft Rejection, and Graft Failure

  2019cites this paper
• Cyclophosphamide and fludarabine monophosphate dose optimization for the non-myeloablative condition in non-human primates to induce transient mixed chimerism via bone marrow transplantation.

  2019cites this paper
• Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen

  2019cites this paper
• Alternative donor transplants for severe aplastic anemia.

  2018cites this paper
• Autologous cord blood transplantation in children with acquired severe aplastic anemia

  2018cites this paper
• Optimal conditioning regimen for haplo‐identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de‐escalation study of TBI and ATG dose

  2018cites this paper
• Aplastic Anemia-Diagnostics and Therapy of Acquired Aplastic Anemia

  2018cites this paper
• Recent advances and current challenges in allogeneic stem cell transplantation in patients with acquired severe aplastic anemia

  2018influential citation
• Preparing the Patient for HSCT: Conditioning Regimens and Their Scientific Rationale

  2018cites this paper
• Childhood Aplastic Anemia

  2017cites this paper
• Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.

  2017cites this paper
• Reduced intensity stem cell transplantation with targeted BU from unrelated donor for chronic granulomatous disease

  2017cites this paper
• How I treat acquired aplastic anemia.

  2017influential citation
• Hematological Disorders in Children

  2017influential citation
• Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review

  2017cites this paper
• Hematopoietic cell transplantation for aplastic anemia

  2017cites this paper
• Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure 1 after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia 2 3 Short title : Second UCBT for graft failure in patients with aplastic anemia

  2017cites this paper
• Unrelated Donor Transplants for Acquired Aplastic Anemia

  2017cites this paper
• A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

  2016cites this paper
• A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia.

  2016cites this paper
• Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.

  2016cites this paper
• Recent Developments in Aplastic Anemia Therapy

  2016cites this paper
• Alternative donor transplants for severe aplastic anemia: current experience.

  2016cites this paper
• Allogeneic stem cell transplantation for non-malignant diseases

  2016cites this paper
• Recommendations from the society for diagnosis and therapy of haematological and oncological diseases Guideline Aplastic Anemia-Diagnos tics and Therapy of Acquired Aplastic Anemia

  2016cites this paper
• Hematopoietic stem cell transplantation for acquired aplastic anemia

  2016cites this paper
• Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia

  2016influential citation
• Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

  2016cites this paper
• Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.

  2015cites this paper
• Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.

  2015cites this paper
• Alternative donor transplant of benign primary hematologic disorders

  2015cites this paper
• Telomere length in hematopoietic stem cell transplantation for severe aplastic anemia: is it ready for "prime time"?

  2015cites this paper
• Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia

  2015cites this paper
• The diagnosis and treatment of aplastic anemia: a review

  2015cites this paper
• Aplastic Anemia - Diagnos tics and Therapy of Acquired Aplastic Anemia

  2015cites this paper
• Updates in acquired aplastic anemia: Can we do more for our patients?

  2015cites this paper
• Cyclophosphamide^|^mdash;associated cardiomyopathy after allogeneic hematopoietic stem cell transplantation from a sibling donor for refractory cytopenia of childhood

  2014cites this paper
• Combined use of Chinese medicine with allogeneic hematopoietic stem cell transplantation for severe aplastic anemia patients

  2014cites this paper
• Outcomes of hematopoietic cell transplantation in adult patients with acquired aplastic anemia using intermediate-dose alemtuzumab-based conditioning.

  2014cites this paper
• Successful rescue of early graft failure in pediatric patients using T-cell-depleted haploidentical hematopoietic SCT

  2014cites this paper
• Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations

  2014cites this paper
• Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation

  2014cites this paper
• Pleurisy as a novel clinical manifestation associated with human herpesvirus 6 after unrelated cord blood transplantation

  2014cites this paper
• Recent advances in treatment of aplastic anemia

  2014cites this paper
• Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia

  2014cites this paper
• Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia

  2013cites this paper
• Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia

  2013cites this paper
• HCT for nonmalignant disorders.

  2013cites this paper
• Gonadal function in patients with severe aplastic anaemia and refractory cytopenia of childhood who undergo bone marrow transplantation after receiving 3‐Gy total body irradiation and high‐dose cyclophosphamide

  2013cites this paper
• Effect of Weight on Outcomes of Children Undergoing Hematopoietic Cell Transplantation

  2013cites this paper
• Current concepts in the pathophysiology and treatment of aplastic anemia.

  2013cites this paper
• anemia second-line treatment for children with severe and very severe aplastic therapy with stem cell transplantation from an alternative donor as Prospective multicenter trial comparing repeated immunosuppressive

  2013cites this paper
• Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation

  2013cites this paper
• Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities.

  2013cites this paper
• Cord blood transplantation in aplastic anemia

  2013cites this paper
• Salvage allogeneic hematopoietic SCT for primary graft failure in children

  2013cites this paper
• Immune Rejection: The Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation (from Mice to Humans)

  2013cites this paper
• Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia

  2013cites this paper
• Allogeneic transplantation for aplastic anemia

  2012cites this paper
• Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

  2012cites this paper
• Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.

  2012cites this paper
• Aplastic anemia: therapeutic updates in immunosuppression and transplantation.

  2012cites this paper
• Matched Sibling Versus Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Children with Severe Acquired Aplastic Anemia: Experience of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

  2012cites this paper
• Striking the right balance: optimizing conditioning regimens for unrelated donor bone marrow transplant for severe aplastic anemia.

  2012cites this paper
• Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning

  2012cites this paper
• How I treat acquired aplastic anemia.

  2012cites this paper
• How I manage aplastic anaemia in children

  2012cites this paper
• Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience

  2012cites this paper
• Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population

  2012cites this paper
• Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

  2011cites this paper